The downregulation of SOAT1 has been found to suppress the proliferation and migration of hepatocellular carcinoma cells by reducing the cholesterol content of the plasma membrane, and then inhibiting the integrin and TGF-β signaling pathways (51). The gene discussed is SOAT1; the disease is hepatocellular carcinoma.